Christopher Easton
Psychiatric/Mental Health · Charleston, WVNPI 1629785175
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 83.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $491 and has fallen 89.5% since, to $52 in 2025. That places this record below the midpoint for psychiatric/mental health clinicians in WV, where the typical reported total is $543.
Across 61 payments — averaging $11.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$582
- Otsuka America Pharmaceutical, Inc.$63
- Mylan Specialty L.p.$35
- Gilead$16
What the payments were for
- Food & beverage$697100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 54 | $582 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Mylan Specialty L.p. | 2 | $35 |
| Gilead | 1 | $16 |
How this compares
$697 in reported general payments places this provider in the 50th percentile of 142 psychiatric/mental health providers in West Virginia.
See all psychiatric/mental health providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 14 | $3,282 |
| Atomoxetine Hcl | 13 | $792 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 37 | $553 |
| Clonazepam | 33 | $402 |
| Trazodone Hcl | 14 | $362 |
| Alprazolam | 75 | $282 |
| Escitalopram Oxalate | 13 | $281 |
| Quetiapine Fumarate | 22 | $247 |
| Mirtazapine | 17 | $190 |
| Bupropion XlBupropion Hcl | 13 | $184 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $177 |
| Bupropion Hcl SrBupropion Hcl | 11 | $104 |
| Fluvoxamine Maleate | 11 | $93 |
| Diazepam | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Charleston
- Zachary MooreCharleston$2K
- Megan KisterCharleston$2K
- Loretta BosticCharleston$2K
- Kayla RoeCharleston$1K
- Allison Nolan-PhillipsCharleston$977
- Derek MorganCharleston$775
- Claudia GibsonCharleston$759
- Jeremy SchreiberWheeling$1.7M
- Kimberly RittenhouseParkersburg$7K
- Michael SkaggsRipley$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.